Rockefeller Capital Management L.P. Raises Stock Holdings in Ventas, Inc. $VTR

Rockefeller Capital Management L.P. raised its holdings in Ventas, Inc. (NYSE:VTR) by 38.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 36,893 shares of the real estate investment trust’s stock after purchasing an additional 10,273 shares during the period. Rockefeller Capital Management L.P.’s holdings in Ventas were worth $2,855,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in VTR. Capital World Investors purchased a new position in shares of Ventas during the 4th quarter valued at approximately $594,116,000. Norges Bank purchased a new stake in Ventas in the 4th quarter worth $474,571,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Ventas by 32,509.3% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,648,776 shares of the real estate investment trust’s stock worth $359,722,000 after acquiring an additional 4,634,520 shares during the period. Cohen & Steers Inc. raised its position in Ventas by 228.1% during the fourth quarter. Cohen & Steers Inc. now owns 4,606,355 shares of the real estate investment trust’s stock worth $356,440,000 after acquiring an additional 3,202,323 shares during the period. Finally, Daiwa Securities Group Inc. lifted its holdings in Ventas by 188.7% during the fourth quarter. Daiwa Securities Group Inc. now owns 4,705,591 shares of the real estate investment trust’s stock valued at $364,119,000 after purchasing an additional 3,075,450 shares in the last quarter. 94.18% of the stock is currently owned by hedge funds and other institutional investors.

Ventas Trading Up 0.0%

Shares of VTR stock opened at $89.06 on Monday. Ventas, Inc. has a 1-year low of $61.76 and a 1-year high of $91.06. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.25. The company has a 50-day moving average of $85.21 and a two-hundred day moving average of $82.80. The firm has a market cap of $43.30 billion, a PE ratio of 161.92, a price-to-earnings-growth ratio of 1.91 and a beta of 0.71.

Ventas (NYSE:VTR) last released its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter last year, the company earned $0.84 earnings per share. The firm’s revenue for the quarter was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, analysts predict that Ventas, Inc. will post 3.88 EPS for the current year.

Ventas Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be issued a $0.52 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.3%. Ventas’s payout ratio is 378.18%.

Insider Buying and Selling at Ventas

In other news, Director Michael J. Embler bought 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were purchased at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the purchase, the director owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the sale, the director directly owned 28,349 shares in the company, valued at approximately $2,557,079.80. This represents a 3.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.53% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on VTR. Mizuho set a $98.00 target price on shares of Ventas in a research report on Friday, May 22nd. Raymond James Financial assumed coverage on shares of Ventas in a research report on Tuesday, June 16th. They set an “outperform” rating and a $94.00 price target for the company. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $100.00 price target on shares of Ventas in a research note on Tuesday, June 16th. Wells Fargo & Company lifted their price objective on Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Finally, KeyCorp boosted their price objective on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $96.00.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.